These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
563 related articles for article (PubMed ID: 1325513)
21. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS study)"]. Düsing R; Müller U MMW Fortschr Med; 2003 Oct; 145 Suppl 3():77-80. PubMed ID: 15490771 [TBL] [Abstract][Full Text] [Related]
22. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS Study)"]. Düsing R; Müller U MMW Fortschr Med; 2003 Oct; 145(40):46. PubMed ID: 14603605 [No Abstract] [Full Text] [Related]
23. Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure. Tang WH; Vagelos RH; Yee YG; Fowler MB Am Heart J; 2004 Nov; 148(5):889-94. PubMed ID: 15523323 [TBL] [Abstract][Full Text] [Related]
24. Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension. Hermida RC; Ayala DE; Fontao MJ; Mojón A; Alonso I; Fernández JR Chronobiol Int; 2010 May; 27(3):560-74. PubMed ID: 20524801 [TBL] [Abstract][Full Text] [Related]
25. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension. van den Meiracker AH; Admiraal PJ; Derkx FH; Kleinbloesem C; Man in 't Veld AJ; van Brummelen P; Mulder P; Schalekamp MA J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the acute and chronic antihypertensive effect of two once-daily doses of spirapril by invasive twenty-four-hour ambulatory blood pressure monitoring. van den Meiracker AH; Man in 't Veld AJ; Ritsema van Eck HJ; Schalekamp MA J Hypertens Suppl; 1989 Dec; 7(6):S302-3. PubMed ID: 2561145 [TBL] [Abstract][Full Text] [Related]
27. Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor. van den Broek SA; de Graeff PA; Smit AJ; Girbes AR; Journée ; van Gilst WH; Hillege H; van Veldhuisen DJ; Wesseling H; Lie KI J Cardiovasc Pharmacol; 1995 Jan; 25(1):105-12. PubMed ID: 7723338 [TBL] [Abstract][Full Text] [Related]
28. Antihypertensive activity of Salvia elegans Vahl. (Lamiaceae): ACE inhibition and angiotensin II antagonism. Jiménez-Ferrer E; Badillo FH; González-Cortazar M; Tortoriello J; Herrera-Ruiz M J Ethnopharmacol; 2010 Jul; 130(2):340-6. PubMed ID: 20488233 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension. Pittrow DB; Antlsperger A; Welzel D; Wambach G; Schardt W; Weidinger G Cardiovasc Drugs Ther; 1997 Nov; 11(5):619-27. PubMed ID: 9493699 [TBL] [Abstract][Full Text] [Related]
30. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril. Edling O; Bao G; Feelisch M; Unger T; Gohlke P J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177 [TBL] [Abstract][Full Text] [Related]
31. Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension. Noble S; Sorkin EM Drugs; 1995 May; 49(5):750-66. PubMed ID: 7601014 [TBL] [Abstract][Full Text] [Related]
32. Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril). Baum T; Watkins RW; Sybertz EJ; Ahn HS; Nelson S; Coleman W; Tedesco R; Pula KK; Rivelli M; Sabin C Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):230-45. PubMed ID: 2884941 [TBL] [Abstract][Full Text] [Related]
33. Antiproteinuric versus antihypertensive effects of high-dose ACE inhibitor therapy. Haas M; Leko-Mohr Z; Erler C; Mayer G Am J Kidney Dis; 2002 Sep; 40(3):458-63. PubMed ID: 12200795 [TBL] [Abstract][Full Text] [Related]
34. Low-dose enalapril reduces angiotensin II and attenuates diabetic-induced cardiac and autonomic dysfunctions. Malfitano C; De Angelis K; Fernandes T; Wichi RB; Rosa K; Pazzine M; Mostarda C; Ronchi FA; Oliveira EM; Casarini DE; Irigoyen MC J Cardiovasc Pharmacol; 2012 Jan; 59(1):58-65. PubMed ID: 21921804 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of spirapril, a new ace-inhibitor, in elderly hypertensive patients. Kantola I; Terént A; Honkanen T; Järveläinen V; Ekman K; Kataja M Eur J Clin Pharmacol; 1996; 50(3):155-9. PubMed ID: 8737752 [TBL] [Abstract][Full Text] [Related]
36. A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension. Nørgaard K; Jensen T; Christensen P; Feldt-Rasmussen B Blood Press; 1993 Dec; 2(4):301-8. PubMed ID: 8173700 [TBL] [Abstract][Full Text] [Related]
37. ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension. Petersen JR; Drabaek H; Gleerup G; Mehlsen J; Petersen LJ; Winther K Angiology; 1996 Mar; 47(3):233-40. PubMed ID: 8638865 [TBL] [Abstract][Full Text] [Related]
38. Effects of acute and chronic angiotensin converting enzyme inhibition by spirapril on cardiovascular regulation in essential hypertensive patients. Assessment by spectral analysis and haemodynamic measurements. Veerman DP; Douma CE; Jacobs MC; Thien T; Van Montfrans GA Br J Clin Pharmacol; 1996 Jan; 41(1):49-56. PubMed ID: 8824693 [TBL] [Abstract][Full Text] [Related]
39. Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension. Shohat J; Wittenberg C; Erman A; Rosenfeld J; Boner G Scand J Urol Nephrol; 1999 Feb; 33(1):57-62. PubMed ID: 10100366 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of spirapril in mild-to-moderate hypertension. Hayduk K; Kraul H J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 1():S19-23. PubMed ID: 10499560 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]